Drug Profile
TW 004
Alternative Names: TW004Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Treeway
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for research development in Amyotrophic-lateral-sclerosis in Netherlands
- 05 Jan 2016 Early research in Amyotrophic lateral sclerosis in Netherlands (unspecified route) before January 2016